Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Sep 27 2024

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated September 27, 2024, titled "Zydus and CSIR-Central Drug Research Institute Lucknow to develop best-in-class drug for Chronic Kidney Disease induced Osteoporosis".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases